NCT01262521

Brief Summary

An expanding number of studies suggest a therapeutic role for nitrate and nitrite, most notably in treatment and prevention of cardiovascular disease including ischemia-reperfusion (IR) injury and hypertension. The nutritional aspects of these cardioprotective effects are particularly intriguing since nitrate and nitrite are abundant in our everyday diet. Whether increasing the circulating pool of nitric oxide and nitrite by dietary nitrate offers a novel mechanistic approach to regulate mobilization of circulating angiogenic cells and thus regenerative processes in cardiovascular medicine is not known. Thus, in the present study, we tested whether oral application of nitrate leads to an enhanced number of circulating angiogenic cells and whether this is associated with an improvement in endothelial function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 16, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 17, 2010

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

November 8, 2013

Status Verified

November 1, 2013

Enrollment Period

1.9 years

First QC Date

December 16, 2010

Last Update Submit

November 7, 2013

Conditions

Keywords

Dietary nitrate

Outcome Measures

Primary Outcomes (1)

  • Circulating angiogenic cells

    4 hours

Secondary Outcomes (2)

  • Cytokines

    4 hours

  • Endothelial function

    4 hours

Study Arms (2)

Dietary nitrate

EXPERIMENTAL

150 ml tab water with 150 umol/kg sodium-nitrate

Dietary Supplement: Dietary nitrate

Water

PLACEBO COMPARATOR

150 ml Chapelle mineral water

Dietary Supplement: Water

Interventions

Dietary nitrateDIETARY_SUPPLEMENT

150 ml tab water with 150 umol/kg sodium-nitrate

Also known as: sodium nitrate
Dietary nitrate
WaterDIETARY_SUPPLEMENT

150 ml Chapelle mineral water

Also known as: H2O
Water

Eligibility Criteria

Age21 Years - 36 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • age \> 20 years
  • refrain from nitrate containing food ingestion during trial

You may not qualify if:

  • \> 36 years
  • poor endothelial function
  • acute infection
  • any chronic heart or pulmonary disease
  • arrhythmias
  • acute or chronic renal failure
  • cardio-vascular risk factors: diabetes mellitus, hypertension, hyperlipidemia
  • intake of nutrition supplements (l-arginine, creatinine)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Heinrich-Heine-University

Düsseldorf, North Rhine-Westphalia, 40225, Germany

Location

Related Links

MeSH Terms

Interventions

sodium nitrateWater

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Study Officials

  • Tienush Rassaf, MD, PhD

    University of Duesseldorf

    STUDY CHAIR
  • Christian Meyer, MD

    University of Duesseldorf

    PRINCIPAL INVESTIGATOR
  • Christian Heiss, MD

    University of Duesseldorf

    PRINCIPAL INVESTIGATOR
  • Malte Kelm, MD, PhD

    University of Duesseldorf

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Christian Meyer, MD

Study Record Dates

First Submitted

December 16, 2010

First Posted

December 17, 2010

Study Start

November 1, 2010

Primary Completion

October 1, 2012

Study Completion

December 1, 2012

Last Updated

November 8, 2013

Record last verified: 2013-11

Locations